Skip to content
kortuc
Menu
  • Technology
  • product
  • pipeline
  • News
  • contact
  • English
    • 日本語
    • English

News

kortucNews
News

We participated in BIO Partnering at JPM etc

Over the last two months, we p …

News

Results showing high efficacy and tolerable safety of Kortuc in several radioresistant cancer types were published in Molecular and Clinical Oncology. This shows KORTUC has potential to treat various types of cancer that are radioresistant

Results of the clinical use of …

News

KORTUC is to attend BIO CEO & Investor Conference in February

KORTUC will participate in BIO …

News

KORTUC Inc. closed financing from SBI Investment to accelerate Pivotal Phase II study in UK and US

Today KORTUC Inc. (KORTUC) ann …

News

KORTUC Inc. started research collaboration with Okayama University on the tumor immunity by a novel radiosensitizer

KORTUC Inc. announced today th …

News

KORTUC is featured in the leading story in “Science Japan”

KORTUC is featured in the lead …

News

Results showing high efficacy of Kortuc in treating locally advanced or recurrent breast cancer were published in Molecular and Clinical Oncology. These predict a positive outcome of the current pivotal Phase 2 study

The results of clinical resear …

News

KORTUC’s basic research result of tumor reoxygenation was presented at ESTRO 2021

The result of a basic research …

News

KORTUC Inc. closed financing from AXA Japan to accelerate Pivotal Phase II study of novel radiosensitizer for cancer radiotherapy

Businesswire Today KORTUC Inc. …

News

Rationale and outcome in various cancer types in clinical practices in Japan were presented at ENA

At ENA 2020 (32nd EORTC-NCI-AA …

Posts navigation

Older posts

Categories

  • News

Recent Posts

  • We participated in BIO Partnering at JPM etc
  • Results showing high efficacy and tolerable safety of Kortuc in several radioresistant cancer types were published in Molecular and Clinical Oncology. This shows KORTUC has potential to treat various types of cancer that are radioresistant
  • KORTUC is to attend BIO CEO & Investor Conference in February
  • KORTUC Inc. closed financing from SBI Investment to accelerate Pivotal Phase II study in UK and US
  • KORTUC Inc. started research collaboration with Okayama University on the tumor immunity by a novel radiosensitizer

Archives

  • March 2022
  • January 2022
  • November 2021
  • October 2021
  • September 2021
  • August 2021
  • July 2021
  • October 2020
  • July 2020
  • June 2020
  • November 2019
  • August 2019
  • March 2017
Copyright © 2022 kortuc – OnePress theme by FameThemes